TrialFind
Saved trials
Back to results
Unknown
Phase 2
Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer
NCT05512416
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
View on ClinicalTrials.gov
Official details
Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer — TrialFind